TCI Wealth Advisors, Inc. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 178 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,876
-33.3%
582
-15.0%
0.00%
-100.0%
Q4 2022$4,309
-38.4%
685
-0.1%
0.00%0.0%
Q3 2022$7,000
-12.5%
686
+0.1%
0.00%0.0%
Q2 2022$8,000
+33.3%
6850.0%0.00%0.0%
Q1 2022$6,000
+20.0%
685
+116.8%
0.00%0.0%
Q4 2021$5,0000.0%316
+64.6%
0.00%0.0%
Q3 2021$5,000
+66.7%
192
+159.5%
0.00%0.0%
Q1 2021$3,000740.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders